By Carl E. Orringer
A 55-year-old South Asian Indian physician comes to you for management recommendations for primary prevention of atherosclerotic cardiovascular disease (ASCVD). He has no current cardiovascular symptoms.
He has an eight-year history of well-controlled arterial hypertension, for which he has been treated with lisinopril 10 mg daily. He is a nonsmoker, has no history of diabetes and has never taken treatment for a lipid disorder. His father had an MI at age 52.
From Cardiovascular Business:
By Candace Stuart
The National Lipid Association (NLA) published recommendations that are designed to help fill the gaps in the 2013 cholesterol guidelines jointly released by two cardiology associations. The report aligns with some aspects of the guidelines but diverges on cholesterol targets.
September 24 is Familial Hypercholesterolemia (FH) Awareness Day. It was initiated by the FH Foundation as part of their mission to raise awareness of FH in the public. As a supporter of this initiative, the National Lipid Association (NLA) and the Foundation of the NLA would like to help bring awareness to this important day and support the FH Foundation’s efforts. Please click here for more information on this important day and how you can spread the word.
.jpg)
.png)
